|

Esketamine 56 mg Clinical Trials

1 actively recruiting trial across 1 location

No change since July 2026

Also known as: JNJ-54135419

Pipeline

Phase 3: 1

Top Sponsors

  • Janssen Research & Development, LLC1

Indications

  • Depressive Disorder, Treatment-Resistant1
  • Depression1

Skokie, Illinois1 trial

A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant Depression

Psychiatric Medicine Associates LLC

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.